CHD1L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.498000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.393600E-01
Normal-vs-Stage2
4.246000E-01
Normal-vs-Stage3
3.007200E-01
Normal-vs-Stage4
7.844200E-01
Stage1-vs-Stage2
9.739800E-01
Stage1-vs-Stage3
4.344400E-01
Stage1-vs-Stage4
7.524400E-01
Stage2-vs-Stage3
2.100600E-01
Stage2-vs-Stage4
6.651200E-01
Stage3-vs-Stage4
1.815220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.557400E-01
Normal-vs-AfricanAmerican
9.897400E-01
Normal-vs-Asian
3.714000E-01
Caucasian-vs-AfricanAmerican
2.785600E-01
Caucasian-vs-Asian
6.135400E-01
AfricanAmerican-vs-Asian
1.571600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.057600E-01
Normal-vs-Female
4.018000E-01
Male-vs-Female
7.649800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.573400E-01
Normal-vs-Age(41-60Yrs)
6.540000E-01
Normal-vs-Age(61-80Yrs)
4.858200E-01
Normal-vs-Age(81-100Yrs)
8.371000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.906800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.651600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.878800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.740000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.915600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.248600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.618400E-01
Normal-vs-Daily Drinker
4.145200E-01
Normal-vs-Weekly Drinker
7.080200E-01
Normal-vs-Occasional Drinker
7.056800E-01
Normal-vs-Social Drinker
2.905800E-01
Non Drinker-vs-Daily Drinker
6.819900E-02
Non Drinker-vs-Weekly Drinker
5.314400E-01
Non Drinker-vs-Occasional Drinker
4.785800E-01
Non Drinker-vs-Social Drinker
5.598200E-01
Daily Drinker-vs-Weekly Drinker
2.670100E-02
Daily Drinker-vs-Occasional Drinker
1.775730E-02
Daily Drinker-vs-Social Drinker
2.554000E-01
Weekly Drinker-vs-Occasional Drinker
9.801000E-01
Weekly Drinker-vs-Social Drinker
2.690600E-01
Occasional Drinker-vs-Social Drinker
2.350000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.842000E-01
Normal-vs-Grade 2
1.653770E-01
Normal-vs-Grade 3
1.873390E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.433600E-01
Grade 1-vs-Grade 3
7.562000E-01
Grade 1-vs-Grade 4
3.842000E-01
Grade 2-vs-Grade 3
6.712200E-01
Grade 2-vs-Grade 4
1.653770E-01
Grade 3-vs-Grade 4
1.873390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.580000E-01
Normal-vs-NonDiabetic
5.549000E-01
Diabetic-vs-NonDiabetic
1.866440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.728200E-01
Normal-vs-NoPancreatitis
5.004000E-01
Pancreatitis-vs-NoPancreatitis
4.060000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.624600E-01
Normal-vs-N1
3.526800E-01
N0-vs-N1
1.298350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.687200E-01
Normal-vs-TP53-NonMutant
5.880000E-01
TP53-Mutant-vs-TP53-NonMutant
5.257600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
